HCPCS Code for Iron Dextran

Iron deficiency anemia (IDA) is a common condition affecting millions worldwide, particularly in individuals with chronic kidney disease, gastrointestinal disorders, or heavy menstrual bleeding. For patients who cannot tolerate oral iron supplements or require rapid iron replenishment, intravenous (IV) iron therapy, such as iron dextran, is often prescribed.

Understanding the HCPCS (Healthcare Common Procedure Coding System) code for iron dextran (J1750) is crucial for healthcare providers, medical coders, and billing specialists to ensure accurate claims processing and reimbursement. This article provides an in-depth exploration of iron dextran, its HCPCS coding, administration guidelines, billing best practices, and safety considerations.

2. Understanding HCPCS Codes

HCPCS codes are standardized medical codes used for billing Medicare, Medicaid, and other insurance providers. They are divided into two levels:

• Level I: CPT (Current Procedural Terminology) codes maintained by the American Medical Association (AMA).

• Level II: Codes for non-physician services, including drugs, supplies, and equipment.

Iron dextran falls under Level II HCPCS codes, specifically J1750.

 HCPCS Code Structure for Iron Dextran

3. What is Iron Dextran?

Iron dextran is a parenteral iron supplement used to treat iron deficiency anemia when oral iron is ineffective or contraindicated. It consists of iron hydroxide complexed with dextran, allowing slow release and reduced toxicity.

Key Features:

• Brand Names: Infed®, DexFerrum®

• Available Forms: IV or IM injection

• Mechanism: Replenishes iron stores for hemoglobin synthesis

4. Medical Uses of Iron Dextran

Iron dextran is prescribed for:

• Chronic kidney disease (CKD)-related anemia

• Inflammatory bowel disease (IBD) with malabsorption

• Heavy menstrual bleeding (menorrhagia)

• Post-bariatric surgery patients with iron deficiency

5. HCPCS Code for Iron Dextran: J1750

The HCPCS code J1750 is used for billing 50 mg of iron dextran.

Billing Guidelines:

• Single-dose billing: Each 50 mg unit is billed separately.

• Documentation: Medical records must justify medical necessity.

• Modifiers: May require JW (discarded drug) or JA (administered intravenously).

Dosage and Corresponding HCPCS Units

6. Dosage and Administration

IV Administration:

• Test Dose: 25 mg (to check for hypersensitivity).

• Total Dose Calculation: Based on patient weight and hemoglobin deficit.

IM Administration (Less Common):

• Z-track technique to prevent staining.

7. Billing and Reimbursement Guidelines

• Medicare Coverage: Covered under Part B for qualified patients.

• Prior Authorization: Some insurers require pre-approval.

• Denial Prevention: Ensure proper documentation (e.g., lab results confirming iron deficiency).

8. Common Side Effects and Precautions

Adverse Effects:

• Hypersensitivity reactions (anaphylaxis risk)

• Hypotension

• Arthralgia and myalgia

Contraindications:

• Allergy to iron dextran

• Non-iron deficiency anemia

9. Comparison with Other IV Iron Formulations

10. Regulatory and Safety Considerations

• FDA Black Box Warning: Risk of anaphylaxis.

• Monitoring: Vital signs during infusion.

11. FAQs

Q1: What is the HCPCS code for 100 mg of iron dextran?

A: Bill 2 units of J1750 (50 mg × 2).

Q2: Can iron dextran be given intramuscularly?

A: Yes, but IV is preferred due to better absorption.

Q3: Does Medicare cover iron dextran infusions?

A: Yes, if medically necessary (e.g., CKD with anemia).

12. Conclusion

Iron dextran (HCPCS J1750) is a vital treatment for iron deficiency anemia when oral iron fails. Proper coding, dosing, and safety protocols ensure effective patient care and reimbursement. Healthcare providers must stay updated on billing guidelines and monitor for adverse effects.

13. Additional Resources

• CMS HCPCS Code Lookup: https://www.cms.gov/medicare/coding

• FDA Iron Dextran Label: https://www.accessdata.fda.gov

• National Kidney Foundation Guidelines: https://www.kidney.org